Pediatric Hematology/Oncology Ambulatory Care Pharmacist Mayo Clinic Rochester, Minnesota, United States
Disclosure(s):
Catherine Martin, PharmD, BCOP: No financial relationships to disclose
Session Description:Infant leukemia is a rare disease with significantly worse outcomes when compared to childhood leukemias. This breakout session will review appropriate management to arm healthcare professionals to treat these complex patients. Additionally, recently published literature, including upfront blinatumomab, will be discussed along with practical considerations for implementing these changes.
Learning Objectives:
Describe the epidemiology, pathophysiology, and characteristics of infant leukemia
Summarize literature guiding treatment of infant leukemia
